Tag: Diagnostics


  • Beauty Tech and AI: Italy’s Tech Week Drives Innovation

    Beauty Tech and AI: Italy’s Tech Week Drives Innovation

    Beauty Tech Takes Center Stage at Italy’s Tech Week Italy’s tech calendar this autumn featured a compelling cross-section of innovation, from AI-driven beauty breakthroughs to the regulated expansion of digital gaming. The Italian Tech Week in Torino highlighted the rapid evolution of Beauty Tech, where cosmetic science blends with data, robotics, and intelligent design. While…

  • New AI Enhances View Inside Fusion Energy Systems

    New AI Enhances View Inside Fusion Energy Systems

    AI-Driven diagnostics: a new view into fusion plasma A cutting-edge artificial intelligence (AI) approach is changing how scientists monitor and control fusion plasma. The Diag2Diag system analyzes data from multiple sensors in a fusion device and generates a synthetic dataset for a different type of diagnostic. In short, AI fills in missing data by learning…

  • World-first LAF assay reveals hidden interactions in blood

    World-first LAF assay reveals hidden interactions in blood

    World-first LAF assay: a new lens on blood chemistry A team at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has unveiled a world-first assay that rapidly measures interactions between nanoscale particles in the bloodstream. The lipoprotein association fluorometry (LAF) technique can deliver results in about one hour, a dramatic improvement over…

  • World-first LAF assay reveals hidden blood particle interactions

    World-first LAF assay reveals hidden blood particle interactions

    Breakthrough in Blood Biology: The LAF Assay A team at the Australian Institute for Bioengineering and Nanotechnology (AIBN) has unveiled a world-first assay that can measure interactions between tiny particles in the bloodstream in just one hour. Lipoprotein association fluorometry, or LAF, was developed by PhD student Raluca Ghebosu under the supervision of AIBN’s Joy…

  • World-first LAF Assay Reveals Hidden Blood Interactions in Cancer

    World-first LAF Assay Reveals Hidden Blood Interactions in Cancer

    World-first LAF assay accelerates cancer research A groundbreaking technique developed at the Australian Institute for Bioengineering and Nanotechnology (AIBN) is redefining how scientists study the bloodstream’s tiniest particles. Lipoprotein Association Fluorometry (LAF) is a world-first assay that can rapidly measure interactions between extracellular vesicles (EVs) and lipoproteins—crucial steps in understanding how cancers develop, spread, and…

  • Large Language Models in Lung Cancer: A Comprehensive Systematic Review

    Large Language Models in Lung Cancer: A Comprehensive Systematic Review

    Introduction: The Rise of LLMs in Lung Cancer Care Large language models (LLMs) are increasingly explored as tools to assist in the full cycle of lung cancer (LC) management, from prevention and screening to diagnosis, treatment planning, and supportive care. This systematic review synthesizes recent evidence on how LLMs are being applied to LC, what…

  • Real-time Bacteria Identification Device Debuts in Viseu

    Real-time Bacteria Identification Device Debuts in Viseu

    Overview: a new real-time bacterial detector coming to Portugal A groundbreaking device that can identify bacteria in humans, animals, and the surrounding environment in real time and indicate the most effective antibiotic is set to be unveiled in Viseu this Friday. The technology, developed by ALS as part of the SMARTgNOTICS consortium—a collaboration of Portuguese…

  • KRISS Develops Revolutionary Diagnostic Platform for Alzheimer’s Detection

    KRISS Develops Revolutionary Diagnostic Platform for Alzheimer’s Detection

    In a groundbreaking achievement, the Korea Research Institute of Standards and Science (KRISS), under the leadership of President Lee Ho Seong, has unveiled a revolutionary diagnostic platform aimed at the early detection of Alzheimer’s disease biomarkers in body fluids. This innovative technology presents a significant leap in the ability to identify the unique markers associated…

  • KRISS Develops Ultra-Sensitive Platform for Alzheimer’s Biomarker Detection

    KRISS Develops Ultra-Sensitive Platform for Alzheimer’s Biomarker Detection

    In a groundbreaking advancement that holds promise for Alzheimer’s research, the Korea Research Institute of Standards and Science (KRISS) has successfully developed a unique diagnostic platform capable of detecting Alzheimer’s biomarkers in body fluids with remarkable precision. This innovative technology, directed by KRISS President Lee Ho Seong, amplifies optical signals of specific molecules by more…